PreciseDx
Marcel Prastawa has been working in the field of machine learning since 2013. Marcel started as a Lead Scientist at GE Global Research in 2013, then became the Director of Machine Learning at the Icahn School of Medicine at Mount Sinai in 2015, and is currently a Senior Machine Learning Scientist at PreciseDx since 2021.
Marcel Prastawa earned a Ph.D. in Computer Science from the University of North Carolina at Chapel Hill and a B.S. in Computer Science and Mathematics from Purdue University.
PreciseDx
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes.